$NEPH Income Statement | Understand Stock

$NEPH

$3.51 -$0.12 (3.31%) Close

$NEPH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net revenues
Product
Royalty and Other Revenues
Total net revenues
Cost of goods sold
Gross Margin
Operating expenses:
Research and development
Depreciation and amortization
Selling, general and administrative
Total operating expenses
Operating income
Other (expense) income:
Interest expense
Interest income
Extinguishment of PPP loan
Other expense net
Total other income

Income before income taxes
Income tax expense
Net income (loss)
Net loss from discontinued operations
Less: undeclared deemed dividend attributable to noncontrolling interest
Net loss attributable to Nephros, Inc. shareholders
Net loss per common share, basic and diluted
Weighted average common shares outstanding, basic and diluted
Net loss per common share, basic from continuing operations
Net loss per common share, basic from discontinued operations
Net loss per common share, diluted from discontinued operations
Net loss per common share, basic
Net loss per common share, basic, attributable to continuing noncontrolling interest
Net loss per common share, diluted, attributable to continuing noncontrolling interest
Net income
Net income per common share, basic
Net income per common share, diluted
Weighted average common shares outstanding, basic
Weighted average common shares outstanding, diluted
Other comprehensive loss, foreign currency translation adjustments, net of tax
Comprehensive loss
Comprehensive loss attributable to Nephros, Inc. shareholders

Comments